1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2015" provides data on the Neovascular Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neovascular Glaucoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015
Introduction 6
Neovascular Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Neovascular Glaucoma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Neovascular Glaucoma Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Gene Signal International SA 32
Clinical Trial Overview of Gene Signal International SA 32
ODIN Biotech Partners, LLC 33
Clinical Trial Overview of ODIN Biotech Partners, LLC 33
Clinical Trial Overview of Top Institutes / Government 34
Kumamoto University 34
Clinical Trial Overview of Kumamoto University 34
Federal University of Sao Paulo 35
Clinical Trial Overview of Federal University of Sao Paulo 35
University of Illinois 36
Clinical Trial Overview of University of Illinois 36
Shimane University 37
Clinical Trial Overview of Shimane University 37
Universidade Federal de Uberlandia 38
Clinical Trial Overview of Universidade Federal de Uberlandia 38
Hong Kong Eye Hospital 39
Clinical Trial Overview of Hong Kong Eye Hospital 39
University of Lubeck 40
Clinical Trial Overview of University of Lubeck 40
Faculty of Medicine Siriraj Hospital, Mahidol University 41
Clinical Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University 41
Shahid Beheshti University of Medical Sciences 42
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 42
Cairo University 43
Clinical Trial Overview of Cairo University 43
Five Key Clinical Profiles 44
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66

List of Tables

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Neovascular Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Neovascular Glaucoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Neovascular Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Neovascular Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015* 32
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ODIN Biotech Partners, LLC, 2015* 33
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015* 34
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 35
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2015* 36
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 37
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Uberlandia, 2015* 38
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 39
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Lubeck, 2015* 40
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Medicine Siriraj Hospital, Mahidol University, 2015* 41
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 42
Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015* 43

List of Figures

Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.